Platelet-activating factor induces epigenetic modifications in human mast cells

Journal of Investigative Dermatology

Volumn 135, Issue 12, 2015, Pages 3034-3040

  Damiani, Elisabetta ^a,b   Puebla Osorio, Nahum ^b   Gorbea, Enrique ^b   Ullrich, Stephen E ^b,c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF TEXAS   (United States)

^c Program in Biomathematics and Biostatistics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE 2; HISTONE H3; THROMBOCYTE ACTIVATING FACTOR; CXCR4 PROTEIN, HUMAN; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1;

ACETYLATION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA ACETYLATION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; UPREGULATION; CELL CULTURE; GENETIC EPIGENESIS; GENETICS; METABOLISM; PHYSIOLOGY;

ACETYLATION; CELLS, CULTURED; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENESIS, GENETIC; HUMANS; MAST CELLS; PLATELET ACTIVATING FACTOR; PROMOTER REGIONS, GENETIC; RECEPTORS, CXCR4;

EID: 84948719684     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.336     Document Type: Article

References (52)

1. Adcock IM, Tsaprouni L, Bhavsar P, et al. (2007). Epigenetic regulation of airway inflammation. Curr Opin Immunol 19: 694-700
2. Albert DH, Magoc TJ, Tapang P, et al. (1997). Pharmacology of ABT-491, a highly potent platelet-Activating factor receptor antagonist. Eur J Pharmacol 325: 69-80
3. Aponte M, Jiang W, Lakkis M, et al. (2008). Activation of platelet-Activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer. Cancer Res 68: 5839-48
4. Arya M, Shergill IS, Williamson M, et al. (2005). Basic principles of real-Time quantitative PCR. Expert Rev Mol Diagn 5: 209-19
5. Balasubramanyam K, Varier RA, Altaf M, et al. (2004). Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferasedependent chromatin transcription. J Biol Chem 279: 51163-71
6. Bussolati B, Biancone L, Cassoni P, et al. (2000). PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-Angiogenesis. Am J Pathol 157: 1713-25
7. Butterfield JH, Weiler D, Dewald G, et al. (1988). Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12: 345-55
8. Byrne SN, Limón-Flores AY, Ullrich SE. (2008). Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. J Immunol 180: 4648-55
9. Cameron EE, Bachman KE, Myohanen S, et al. (1999). Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103-7
10. Chacón-Salinas R, Chen L, Chávez-Blanco AD, et al. (2014). An essential role for platelet-Activating factor in activating mast cell migration following ultraviolet irradiation. J Leukoc Biol 95: 139-48
11. Chacón-Salinas R, Limón-Flores AY, Chávez-Blanco AD, et al. (2011). Mast cellderived IL-10 suppresses germinal center formation by affecting T follicular helper cell function. J Immunol 186: 25-31
12. Cheung P, Allis CD, Sassone-Corsi P. (2000). Signaling to chromatin through histone modifications. Cell 103: 263-71
13. Conte M, Dell'Aversana C, Benedetti R, et al. (2014). HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. Oncotarget 6: 886-901
14. Counts JL, Goodman JI. (1995). Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83: 13-5
15. Denizot Y, De Armas R, Caire F, et al. (2006). Platelet-Activating factor and human meningiomas. Neuropathol Appl Neurobiol 32: 674-8
16. Denizot Y, Descottes B, Truffinet V, et al. (2005). Platelet-Activating factor and liver metastasis of colorectal cancer. Int J Cancer 113: 503-5
17. Dy LC, Pei Y, Travers JB. (1999). Augmentation of ultraviolet B radiation-induced tumor necrosis factor production by the epidermal platelet-Activating factor receptor. J Biol Chem 274: 26917-1
18. Feuerherm AJ, Jorgensen KM, Sommerfelt RM, et al. (2013). Platelet-Activating factor induces proliferation in differentiated keratinocytes. Mol Cell Biochem 384: 83-94
19. Gong F, Miller KM. (2013). Mammalian DNA repair: HATs and HDACs make their mark through histone acetylation. Mutat Res 750: 23-30
20. Gray SG, Teh BT. (2001). Histone acetylation/deacetylation and cancer: an open and shut case?. Curr Mol Med 1: 401-29
21. Gul H, Marquez-Curtis LA, Jahroudi N, et al. (2009). Valproic acid exerts differential effects on CXCR4 expression in leukemic cells. Leuk Res 34: 235-42
22. Hart PH, Grimbaldeston MA, Swift GJ, et al. (1998). Dermal mast cells determine susceptibility to Ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 187: 2045-53
23. Hildmann C, Riester D, Schwienhorst A. (2007). Histone deacetylases-An important class of cellular regulators with a variety of functions. Appl Microbiol Biotechnol 75: 487-97
24. Jones PA. (2002). DNA methylation and cancer. Oncogene 21: 5358-60
25. Jones PA, Baylin SB. (2007). The epigenomics of cancer. Cell 128: 683-92
26. Juremalm M, Hjertson M, Olsson N, et al. (2000). The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cellderived factor-1alpha acts as a mast cell chemotaxin. Eur J Immunol 30: 3614-22
27. Lehr HA, Weyrich AS, Saetzler RK, et al. (1997). Vitamin C blocks inflammatory platelet-Activating factor mimetics created by cigarette smoking. J Clin Invest 99: 2358-64
28. Li H, Niederkorn JY, Sadegh L, et al. (2013). Epigenetic regulation of CXCR4 expression by the ocular microenvironment. Invest Ophthalmo Vis Sci 54: 234-43
29. Liu X, Wang L, Zhao K, et al. (2008). The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. Nature 451: 846-50
30. Lorant DE, Patel KD, McIntyre TM, et al. (1991). Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 115: 223-34
31. Ma Y, Hwang RF, Logsdon CD, et al. (2013). Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. Cancer Res 73: 3927-7
32. Marathe GK, Johnson C, Billings SD, et al. (2005). Ultraviolet B radiation generates platelet-Activating factor-like phospholipids underlying cutaneous damage. J Biol Chem 280: 35448-57
33. Medzhitov R, Horng T. (2009). Transcriptional control of the inflammatory response. Nat Rev Immunol 9: 692-703
34. Mori T, Kim J, Yamano T, et al. (2005). Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. Cancer Res 65: 1800-7
35. Pazin MJ, Kadonaga JT. (1997). What's up and down with histone deacetylation and transcription?. Cell 89: 325-8
36. Pei Y, Barber LA, Murphy RC, et al. (1998). Activation of the epidermal plateletactivating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol 161: 1954-61
37. Pitton C, Lanson M, Besson P, et al. (1989). Presence of PAF-Acether in human breast carcinoma: relation to axillary lymph node metastasis. J Natl Cancer Inst 81: 1298-302
38. Prescott SM, Zimmerman GA, Stafforini DM, et al. (2000). Platelet-Activating factor and related lipid mediators. Annu Rev Biochem 69: 419-5
39. Przybylski M, Kozlowska A, Pietkiewicz PP, et al. (2010). Increased CXCR4 expression in AsPC1 pancreatic carcinoma cells with RNA interferencemediated knockdown of DNMT1 and DNMT3B. Biomed Pharmacother 64: 254-8
40. Puebla-Osorio N, Damiani E, Bover L, et al. (2015). Platelet-Activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells. Cell Death Dis 6: e1745
41. Ramos EA, Grochoski M, Braun-Prado K, et al. (2011). Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer. PLoS One 6: e29461
42. Rhee I, Bachman KE, Park BH, et al. (2002). DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416: 552-6
43. Sahu RP, Turner MJ, DaSilva SC, et al. (2012). The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-Activating factor agonists. Carcinogenesis 33: 1360-7
44. Sato N, Matsubayashi H, Fukushima N, et al. (2005). The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer. Cancer Biol Ther 4: 70-6
45. Shuto T, Furuta T, Oba M, et al. (2006). Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells. FASEB J 20: 782-4
46. Sreevidya CS, Khaskhely NM, Fukunaga A, et al. (2008). Inhibition of photocarcinogenesis by platelet-Activating factor or serotonin receptor antagonists. Cancer Res 68: 3978-84
47. Stafforini DM, Prescott SM, Zimmerman GA, et al. (1996). Mammalian plateletactivating factor acetylhydrolases. Biochim Biophys Acta 1301: 161-73
48. Suarez-Alvarez B, Baragano Raneros A, Ortega F, et al. (2013). Epigenetic modulation of the immune function: a potential target for tolerance. Epigenetics 8: 694-702
49. Sullivan KE, Reddy AB, Dietzmann K, et al. (2007). Epigenetic regulation of tumor necrosis factor alpha. Mol Cell Biol 27: 5147-60
50. Travers JB, Berry D, Yao Y, et al. (2010). Ultraviolet B radiation of human skin generates platelet-Activating factor receptor agonists. Photochem Photobiol 86: 949-54
51. Walterscheid JP, Ullrich SE, Nghiem DX. (2002). Platelet-Activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med 195: 171-9
52. Yoshikawa T, Rae V, Bruins-Slot W, et al. (1990). Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 95: 530-6